| Motor milestones |
Motor milestones |
USMLE |
2023-03-08 |
Heba666 |
10 |
1 |
edit |
|
| Fetal movements |
Fetal movements |
Unfinished |
2023-03-10 |
Heba666 |
5 |
0 |
edit |
|
| Protein antibiotic |
Antibiotic by protein synthesis |
Unfinished |
2023-11-05 |
Heba666 |
7 |
0 |
edit |
|
| Coverage Cell wall |
Pharmacology antibiotics |
Unfinished |
2023-11-05 |
Heba666 |
9 |
0 |
edit |
|
| Antib- combinations |
Pharmacology cell wall synthesis |
Unfinished |
2023-11-05 |
Heba666 |
3 |
0 |
edit |
|
| Protein synthesis X |
Pharmacology- mechanism of action |
Unfinished |
2023-11-05 |
Heba666 |
8 |
0 |
edit |
|
| SE protein X |
Pharmacology rotein synthesis X |
Unfinished |
2023-11-05 |
Heba666 |
7 |
0 |
edit |
|
| Af chemical mediator |
Pathology acute inflammation chemical mediators |
Unfinished |
2023-11-10 |
Heba666 |
5 |
0 |
edit |
|
| Staph aureus |
Micro gram positive 1 |
USMLE |
2023-11-22 |
Heba666 |
14 |
0 |
edit |
|
| Epidermidis & sapro |
Micro gram positive 2 |
USMLE |
2023-11-22 |
Heba666 |
6 |
0 |
edit |
|
| alpha 1 antagonist |
pharma |
USMLE |
2023-12-25 |
Heba666 |
14 |
0 |
edit |
|
| beta 1 antagonist |
pharma |
USMLE |
2023-12-24 |
Heba666 |
12 |
0 |
edit |
|
| alpha+ beta agonist |
Pharma |
USMLE |
2023-12-25 |
Heba666 |
22 |
0 |
edit |
|
| Anti-protozoal |
pharma |
USMLE |
2023-12-25 |
Heba666 |
25 |
0 |
edit |
|
| Anti fungal |
Pharma |
USMLE |
2023-12-25 |
Heba666 |
37 |
0 |
edit |
|
| Anti-helminth |
Pharma |
USMLE |
2023-12-25 |
Heba666 |
23 |
0 |
edit |
|